Comparison of ELISA with automated ECLIA for IL-6 determination in COVID-19 patients: An Italian real-life experience

Comparison of ELISA with automated ECLIA for IL-6 determination in COVID-19 patients: An Italian real-life experience

Objectives: Coronavirus disease 2019 (COVID-19) has a wide spectrum of clinical severity. A cytokine storm is associated with COVID-19 severity. Of these, IL-6 is significantly associated with higher mortality and is also a marker for predicting disease prognosis. IL-6 may act as a target for therap...

Full description

Bibliographic Details
Main Authors: Francesca Romano, Luisa Lanzilao, Edda Russo, Maria Infantino, Francesca Nencini, Giovanni Cappelli, Stefano Dugheri, Mariangela Manfredi, Alessandra Fanelli, Amedeo Amedei, Nicola Mucci
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Practical Laboratory Medicine
Subjects:
COVID-19
Interleukin-6
ELISA
ECLIA
Online Access:http://www.sciencedirect.com/science/article/pii/S2352551724000386

Internet

http://www.sciencedirect.com/science/article/pii/S2352551724000386

Similar Items